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Mycobacterium tuberculosis, the causative agent of tuberculosis, is an intracellular pathogen
with several survival mechanisms aimed at subverting the host immune system. Apoptosis
has been shown to be mycobactericidal, to activate CD8+ T cells, and to be modulated by
mycobacterial proteins. Since few mycobacterial proteins have so far been directly
implicated in the interactions between M. tuberculosis and host cell apoptosis, we screened
M. tuberculosis H37Rv transposon mutants to identify mutants that fail to inhibit cell death
(FID). One of these FID mutants, FID19, had a transposon insertion in Rv2456c and is
important for survival in host cells. The lack of the protein resulted in enhanced
caspase-3 mediated apoptosis, which is probably due to an inability to activate nuclear
factor-jB. Additionally, FID19 infection enhanced polyfunctional CD8+ T cells and induced
a higher frequency of interferon-c secreting immune cells in a murine model. Taken
together, our data suggest that Rv2456c is important for the survival of H37Rv by subduing
the innate and ultimately adaptive immune responses of its host by preventing apoptosis
of the infected cell. Better understanding of the host-mycobacterial interactions may be
beneficial to develop novel drug targets and engineer more efficacious vaccine strains
against tuberculosis.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction Mycobacterium tuberculosis, an aerobic, acid-fast bacillus thatTuberculosis is a serious global health threat, infecting 9
million new individuals and causing 1.5 million deaths each
year [1]. The prime etiological agent of this disease isdwells inside host cells after infection [2,3]. The pathogen is
transmitted via aerosolized particles from an actively infected
individual [4], and it primarily resides inside host
alveolar macrophages [5]. Once inside its targeted cell, the27710, USA.
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to prevent immune detection and ensure survival.
As apoptosis is bactericidal to M. tuberculosis, it is not sur-
prising that the bacterium has found ways to inhibit this
pathway [6–11]. Cysteine proteases called caspases mediate
apoptosis and are found in the cytoplasm until they are acti-
vated via cleavage at their active site [12]. Varieties of stimuli
are able to induce cell death and can be found either internal
or external to the cell. The Bcl-2 protein family regulates
intrinsic apoptosis via their interactions with the mitochon-
drial membrane and can cause activation of caspase 9 [13].
Conversely, external stimuli such as tumor necrosis factor-a
(TNFa) bind to death receptors on the exterior surface of the
cell to initiate a cascade that activates caspase 8 [14]. These
initiator caspases then activate caspase 3, which subse-
quently executes events that lead to apoptosis of the cell.
M. tuberculosis is able to block both the intrinsic and extrin-
sic apoptotic pathways. The bacterium reduces extrinsic
apoptosis by preventing the secretion of Fas [6] and TNFa
[8,15], as well as by interacting with host proteins [9]. Intrinsic
apoptosis is abrogated through the upregulation of a prosur-
vival Bcl-2 protein,Mcl-1 [10]. Other genes have been identified
as being important in the inhibition of apoptosis [8,16], but the
specificmechanisms remain elusive. Thus, additional study in
this area could uncover novel ways to prevent the survival of
M. tuberculosiswithin host cells. It was reported that inhibition
of apoptosis by M. tuberculosis could prevent cross presenta-
tion and activation of CD8+ T cells [17,18], minimizing the
cytotoxic adaptive immune response. By identifying how the
bacterium is able to subvert host immune responses inmacro-
phages, it may be possible to engineer a nonpathogenic strain
ofM. tuberculosis that enhances immune responses for use as a
vaccine. This is urgently needed, as there is no efficacious vac-
cine against tuberculosis [19,20].
To identify genes that are important in the inhibition of
apoptosis, a transposon mutant library of M. tuberculosis
H37Rv was generated and screened for mutants unable to
inhibit cell death. Mutants were further screened for height-
ened immunogenicity in comparison to the parental strain.
Based on its failure to inhibit apoptosis and to induce an
immune response, fails to inhibit cell death mutant 19
(FID19), a transposon insertion in Rv2456c, was selected for
further study. Our studies aimed to determine how this pro-
tein inhibits apoptosis in the wild type bacterium, if it is
important for survival, and if a mutant lacking this protein
has enhanced immunogenicity in vivo.
Materials and methods
Bacterial strains and culture conditions
M. tuberculosisH37Rv was obtained through the National Insti-
tute of Health Biodefense and Emerging Infectious Research
Resources Repository (BIH-M. tuberculosis, strains H37Rv and
NR-123). An arrayed transposon library containing 9400
mutants was generated through Mariner transposon mutage-
nesis as described previously [21]. The flanking genomic
region of the transposon insertion site was sequenced and
the disrupted gene was complemented by either a plasmidexpressing the single target gene with its promoter or a cos-
mid encoding the gene. A cosmid used for the complementa-
tion was generously provided by Dr. William R. Jacobs, Jr.
(Albert Einstein School of Medicine, New York, NY, USA). To
reduce variability between experiments, freshly frozen bacte-
rial stocks were used for infection. To prepare the stocks, bac-
teria were grown until they reached an optical density
between 0.6 and 0.8. At this point, the cells were washed twice
in phosphate buffered saline (PBS; Gibco, Invitrogen, Carls-
bad, CA) with 0.05% tyloxapol (Sigma–Aldrich, Hamburg,
Germany), passed through a sterile 40 lM filter, and finally
through a sterile 20 lM filter. The optical density of the cul-
ture was then adjusted to 1.2, aliquoted into 1-mL vials, and
quickly frozen using dry ice and ethanol. Mycobacterial liquid
growth media consisted of Middlebrook 7H9media (Difco, BD)
supplemented with 0.5% glycerol (Sigma–Aldrich), 0.05%
tyloxapol (Sigma–Aldrich), and 10% of a solution of oleic acid,
albumin, dextrose, and catalase supplement (BD Diagnostics,
Sparks, MD). For growth plates, Middlebrook 7H10 media was
supplemented with the same components as above. Plates
were grown in incubators at 37 C with 5% CO2 for 3 weeks
or until colonies were visible.
Cell death assay
Human epithelial cells (A549: American Type Culture Collec-
tion, CCL-185) were infected at a multiplicity of infection
(MOI) of 10 for 3 h with the arrayed transposonmutant library.
After this time, cells were washed twice with PBS and fresh
media containing 50 lg/mL of gentamycin was added. The
experiment was allowed to continue for 3 days and the
supernatant was assayed for lactate dehydrogenase (LDH;
Cytotoxicity Detection Kit, Roche, Mannheim, Germany) to
measure membrane damage and cell death. Mutants that
induced significant LDH release were further tested for their
ability to induce death in human monocyte-derived macro-
phages (THP-1: TIB-202, American Type Culture Collection,
Manassas, VA). To measure cell death, THP-1 cells were differ-
entiated with 10 ng/mL of phorbol myristate acetate over-
night, washed twice with PBS, and then infected with an
MOI of 10. THP-1 cells were infected as described above for
4 days after which cells were fixed with 4% formaldehyde
and stained with terminal deoxynucleotidyl transferase
20-deoxyuridine, 50-triphosphate nick-end labeling (TUNEL)
as described in the package insert (In-situ Cell Death Detection
Kit; Roche). Cells were analyzed on a BD FACS Canto or BD
LSRII (Becton Dickinson Biosciences, Rutherford, NJ) after
staining. All flow cytometry data was analyzed using Flowjo
software (TreeStar, Ashland, OR).
Measurement of pyroptosis induction
Small hairpin RNA (shRNA) knockdowns in PYCARD and
NLRP3 in THP-1 cells were generously provided by Dr. Jenny
Ting (University of North Carolina, Chapel Hill, NC, USA)
and are described elsewhere [22]. Cell death was measured
by TUNEL staining and interleukin (IL)-1b secretion was
measured by enzyme-linked immunosorbent assay (ELISA;
eBiosciences, San Diego, USA).
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THP-1 cells were differentiated and infected. After 3 h of
infection, the cells were washed and media containing
50 lg/mL of gentamycin was added for the duration of the
experiment. The cells were either treated with dimethyl
sulfoxide (DMSO) (control), 50 lM of a caspase-3 inhibitor
Z-DEVD-FMK (R&D Systems, Minneapolis, MN) or 50 lM of a
pan-caspase inhibitor Z-VAD-FMK (R&D Systems). After
3 days of infection, apoptosis was measured via TUNEL
staining.Western blotting
Cells were washed twice with PBS and lysed via radioim-
munoprecipitation assay buffer (Sigma–Aldrich) containing
protease and phosphatase inhibitor cocktails (Sigma–Aldrich)
for 10 min on ice. Protein samples originating in the Biosafety
Level 3 (BSL3) laboratory were filtered through 0.22 lM SpinX
columns to remove bacteria. Samples were stored at 80 C
until needed. Proteins were separated on MiniProtean precast
polyacrylamide gels (Bio-Rad, Hercules, CA) and were trans-
ferred onto polyvinylidene fluoride membranes (Bio-Rad).
Membranes were blocked in 5% Tris-buffered saline with
Tween20 (TBST; Sigma–Aldrich) for either 1 h at room temper-
ature or overnight at 4 C. Primary antibodies were added at a
1:1,000 dilution in 5% bovine serum albumin (Sigma–Aldrich)
in TBST at 4 C overnight (b-actin; Genscript, Piscataway, NJ;
myeloid cell leukemia-1 [Mcl-1], nuclear factor [NF]-jB; Cell
Signaling Technology, Boston, MA). The membranes were
then washed with TBST three times for 10 min each, and
secondary antibodies (antimouse horseradish peroxidase;
Genscript; antirabbit horseradish peroxidase; Cell Signaling
Technology) were added at a dilution of 1:5000 for 1 h at room
temperature in 5% bovine serum albumin in TBST.
Membranes were again washed three times, and Lumi-Light
Western Blotting Substrate (Roche) was used for the detection
of proteins. ImageJ software program (US National Institutes
of Health, Bethesda) was used for densitometry analysis and
ratios were utilized to control for differences in loading.Bacterial survival assays
For assessing in vitro survival of H37Rv and FID19, THP-1 cells
were infected at an MOI of 10 as previously described. At indi-
cated time points, cells were washed twice with PBS, and 0.1%
Triton X-100 (Sigma–Aldrich) was added to each well for
10 min. At the end of the lysis period, the homogenate was
plated. For in vivo survival, C57BL/6 J mice were infected via
the retro-orbital intravenous route with 1  107 bacteria. After
3 weeks of infection, the spleens were aseptically removed,
homogenized, and plated. Colony counts were performed
3 weeks after plating to measure colony forming units (CFU).Measurement of NF-jB activation
THP-1 cells were infected at an MOI of 10 for 2 days and then
nuclear extracts were harvested utilizing a nuclear extraction
kit (Abcam, Cambridge, MA). The extracts were filtered andassayed using an NF-jB p50/p65 transcription factor assay
kit (Abcam) that measures p50 and p65 activation. An inhibi-
tor of kappa B, BAY11-7082, was used to prevent NF-jB activa-
tion. Briefly, THP-1 cells were infected at an MOI of 10. DMSO
as a control or BAY11-7082 was added to the infected cells. At
3- and 4-days postinfection, the cells were harvested and
TUNEL stained to determine the effect of blocking NF-jB on
cell death. Data are presented as a ratio of BAY-treated cells
over DMSO-control cells.
In vitro immunogenicity screening
Bone marrow from C57BL/6 J mice (Stock 000664; Jackson
Laboratory, Bar Harbor, ME, USA) was harvested from long
bones, depleted of red blood cells, and differentiated for
6 days in Dulbecco’s Modified Eagle Medium media supple-
mented with penicillin–streptomycin and L929-conditioned
media (20%) as previously described [23]. All bone marrow dif-
ferentiation media was tested to ensure that a population of
CD11b-positive (>95%) bone marrow derived macrophages
(BMDMs) was present after 6 days. On Day 6, BMDMs were
plated into 96-well plates (5  104 cells/well). The following
day, the cells were infected with mycobacterial strains
expressing Ag85-SIIN or 1 lg/mL of SIINFEKL peptide (Ana-
spec, Fremont, CA) was added as a positive control. CD8+ T
cells were purified from OT-1 mice (Stock 004175; Taconic Bio-
sciences Inc., Germantown, NY) via a cell separation method
(MACS columns; Miltenyi Biotec, Auburn, CA) and added at a
ratio of 5:1 OT-1 CD8+ T cells to BMDMs after 3 h of bacterial
infection. The supernatant was collected after 24 h postaddi-
tion of the T cells and assayed for IL-2 and IFNc via ELISA.
In vivo immunogenicity
All in vivo experiments were performed in compliance with
the Institutional Biosafety Committee in a BSL3 facility at
the Regional Containment Laboratory at Duke University,
Durham, NC, USA. All animal studies were performed in
accordance with approval of the Duke University Yale Univer-
sity’s Institutional Animal Care and Use Committee. C57BL/6 J
mice were injected via a retro-orbital intravenous route with
1  107 bacteria. Each inoculum was plated to determine if
the CFU of the initial bacterial burden was consistent between
groups. Mice were sacrificed 3 weeks post injection. For intra-
cellular cytokine staining, the spleens were removed and
mechanically homogenized in splenocyte media (RPMI-1640
media supplemented with 1% of both nonessential amino
acids and penicillin–streptomycin) and lysed with ACK lysis
buffer (Sigma–Aldrich). The cells were counted with a Moxi
cell counter (Orflo, Hailey, ID) and plated at 2  106 cells. For
each mouse, the samples were either left untreated or stimu-
lated with Ag85 (Genscript; 10 lg/mL), Tb10.4 (Genscript;
10 lg/mL), or CD28 (BD: 2 lg/mL) as a positive control.
Golgistop (BD; 0.5 lL/well) was added at the same time as
the stimuli. All samples were performed in duplicate. Cells
were stained for CD4+ (BD, San Jose, CA) and CD8+ (BD) surface
markers and intracellular cytokines IL-2 (BD), TNFa (BD), and
IFNc (BD). Analysis was performed using a BD or L02. For
Enzyme-Linked ImmunoSpot (ELISPOT) analysis, anti-IFNc
antibody (MabTech, Nacka Strand, Sweden) capture antibody
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described above. The cells were stimulated with Ag85
(10 lg/mL), Tb10.4 (10 lg/mL), PPD (5 lg/mL; Statens Serum
Institute, Copenhagen, Denmark), concanavalin A
(Sigma–Aldrich; 10 lg/mL) as a positive control, or left cells
untreated as an unstimulated control. A secondary
antibody (MabTech), avidin peroxidase complex (Vectastain
PK-6100; Vector Laboratories, Burlingame, CA), and
3-amino-9-ethylcarbazole substrate were used for detection.
For removal from the BSL3, the plates were submerged in
freshly made 1:128 Vesphene Ilse for a contact time of
10 min. This was then repeated, after which the plates were
placed in bags and removed from the BSL3. The spots formed
in the wells were counted on a C.T.L. Immunospot Analyzer
(Cellular Technology Limited, Cleveland, OH) for
determination of spot forming units (SFU). SFU per well was
used to calculate the total number of spot-producing cells
per spleen (total SFU).Statistical analysis
All statistical analysis was performed with Graphpad Prism
software (San Diego, USA). A p value < .05 was considered sig-
nificant. All data is presented as means ± standard error of
the means. Student t test were utilized for testing differences
between the two groups and analysis of variance were
employed for comparing more than two groups.Results
Identification of cell death mutants of M. tuberculosis
A transposon mutant library of the common laboratory strain
H37Rv was generated to identify genes that are important in
the inhibition of cell death by M. tuberculosis. Mariner trans-
poson mutagenesis was utilized for its random nature to
insert into the genome between TA nucleotides [21]. The
library consists of 9400 mutants, which should provide three-
fold coverage of the genome when essential genes are
excluded. Human alveolar epithelial cells (A549) were used
in the primary screen, as the cells have been previously used
to evaluate mycobacterial infection-induced apoptosis
[24–26]. Further, they do not require differentiation with phor-
bol 12-myristate 13-acetate like THP-1 cells, which made this
high-throughput screen more manageable. It has been
documented that if not engulfed by neighboring cells or in cell
culture, where phagocytosis does not usually happen, the
cells in the late stages of apoptosis present necrotic features
due to the loss of cellular energy and plasma membrane
integrity. This process is called ‘‘apoptotic necrosis” or ‘‘sec-
ondary necrosis” [27,28]. Thus, we analyzed the ‘‘apoptotic
necrosis” of the A549 cells infected with an individual mutant
using an LDH assay that is a reliable colorimetric method to
quantitatively measure LDH released into the media from
damaged cells. This method identifies mutants that have
potentially undergone necrosis, pyroptosis, or apoptotic
necrosis. In order to identify which mechanism of cell death
occurred after infection with our mutants, secondary
screening employing TUNEL staining (Fig. 1) was performedin THP-1 cells to identify transposon mutants exhibiting an
apoptosis-inducing phenotype. Twenty-three out of 30 candi-
date transposon mutants from the screen consistently
showed a significant increase in TUNEL positivity compared
with the parental strain H37Rv. The interrupted genes, and
therefore those likely to be important in the inhibition of cell
death in wild-type H37Rv, were identified by sequencing the
flanking regions of the transposon insertions. The mutants
listed in Table 1 were confirmed to be proapoptotic and were
numerically identified and termed FID mutants.
It is evident that M. tuberculosis has a multitude of mecha-
nisms to inhibit cell death, as the functional groupings of the
genes as annotated in Tuberculist (http://tuberculist.epfl.ch/)
were diverse. Cell wall and cell wall processes were the most
abundant proteins (34.78%) in this study, followed by those
involved in intermediary metabolism and respiration
(26.09%) and conserved hypotheticals (21.74%). There was dis-
persion of the transposon insertions throughout the genome,
indicating acceptable mutagenesis coverage.
Rv2456c is important for inhibition of cell death and survival
in host cells
FID19 was selected for further analysis based on its ability to
enhance both cell death (Fig. 2B) and in vitro immunogenicity
(Fig. 2D). Based on the sequence analysis, it was determined
that a transposon was inserted between nucleotides 305 and
306 out of 1,257 base pairs of Rv2456c (Fig. 2A). The gene pro-
duct is an integral membrane protein that is involved in
solute transportation across the membrane, with the solute
possibly being a sugar [29]. Complementation was achieved
with expression of the full-length gene on a mycobacterial
replicating plasmid (Fig. 2B). THP-1 cells were infected with
H37Rv, FID19, or a complementation plasmid (FID19::pSL901)
containing Rv2456c and TUNEL-positive cells were deter-
mined at 4 days postinfection. FID19 showed significantly
higher TUNEL positivity comparedwith the parental wild type
H37Rv strain. The complementing strain demonstrated the
same level of apoptosis as the parental strain H37Rv (Fig. 2B).
Survivability of a microbe within host cells is a measure of its
virulence. In the human THP-1 cell model system, there was a
trend, but not a statistically significant decrease in CFU
between 1 day and 3 days post-FID19 infection (Fig. 2C).
Since FID19-infected cells undergo enhanced apoptosis
(Fig. 2B), we would expect to see an increased ability of
FID19 to induce a CD8+ T cell response [17,18]. To test this
hypothesis, we utilized a variation of a previously described
in vitro assay [30,31]. Briefly, BMDMs were infected with
H37Rv or FID19 expressing SIINFEKL. To test this, OT-1 T cells
that only recognized SIINFEKL were added to the infected
BMDMs and T-cell activation was measured via IFNc secre-
tion. Indeed, levels of IFNc secretion were significantly ele-
vated in FID19–SIINFEKL infected cells when compared with
H37Rv-SIIN cells (Fig. 2D). Low levels of IFNc secretion can
be detected in the absence of SIIN expression, specifically in
the uninfected and H3Rv samples. Further, no statistically
significant defect associated with FID19 growth in bacterial
culture media was observed (Fig. 2E). These data suggest that
Rv2456c is the gene that was disrupted through transposon
mutagenesis and is responsible for the enhanced apoptotic
Table 1 – H37Rv Genes Important for Inhibition of Cell Death Identified in this Study.
FID Locus Designation Gene name Function or product
1 Rv1981c nrdF1 Involved in the DNA replication pathway
2 Rv1000c Function unknown
3 Rv0819 mshD Involved in the fourth step of mycothiol biosynthesis
4 Rv1867 Function unknown, but supposed involvement in lipid degradation
5 Rv2948c fadD22 Involved in the biosynthesis of phenolic glycolipids
6 Rv1567c Probable hypothetical membrane protein
7 Rv1436 gap Involved in the 2nd phase of glycolysis
8 Rv3253c Possible cationic amino acid transport integral membrane protein
9 Rv0876c Possible conserved transmembrane protein
10 Rv0110 Probable conserved integral membrane transport protein
11 Rv2019 Unknown, conserved protein
12 Rv1624c Probable conserved membrane protein, similarity to nuoK
13 Rv1781c malQ Probable 4-alpha-glucanotransferase
14 Rv2663 Hypothetical protein
15 Rv2141c Conserved protein
16 Rv3738c PPE66 Unknown
17 Rv1704c cycA Probable D-serine/alanine/glycine transporter
18 Rv1737c narK2 Possible nitrate/nitrite transporter
19 Rv2456c Probable conserved integral membrane transport protein
20 Rv2054 Conserved protein
21 Rv0688 Putative ferredoxin reductase
22 Rv2047c Conserved hypothetical protein
23 Rv1207 folP2 Dihydropteroate synthase 2
Note. FID = Fail to Inhibit cell Death.
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Fig. 1 – Cell death afterMycobacterium tuberculosis transposon mutant infection. THP-1 cells were infected at a multiplicity of
infection of 10 with transposon mutants, H37Rv, left untreated or treated with staurosporine. Cells were harvested and fixed
4-days postinfection, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) stained, and analyzed via flow
cytometry. Data represent a compilation of four experiments.Note: FID = fail to inhibit cell death; STS = staurosporine. *p < .05.
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subset.
Apoptosis, not pyroptosis, mediated host cell death after
FID19 infection
To elucidate how FID19-infected cells have enhanced cell
death, cytokine secretion in infected THP-1 cells was
examined. Secretion of TNFa and IL-1b were elevated
(Fig. 3A and B) in FID19 infected cells when compared with
those infected with the parental strain H37Rv. TNFa, a known
mediator of apoptosis, was secreted at a higher concentration
in FID19 infected cells and decreased over time (Fig. 3A).
H37Rv infection also induced TNFa secretion, but only at the24-h time point, after which cytokine levels were similar to
uninfected cells. Similarly, levels of an inflammatory cyto-
kine, IL-1b, were elevated as early as 24 h postinfection in
FID19 infected cells and the concentration gradually
increased over time, whereas levels in H37Rv infected cells
remained constant (Fig. 3B).
The cytokine secretion profile after FID19 infection sug-
gested that the mutant might also be inducing cell death
through pyroptosis. Pyroptosis is an inflammatory form of
cell death regulated by caspase-1 activation and results in
the secretion of IL-1b. To determine if pyroptosis played a role
in death caused by FID19 infection, shRNA knockdown THP-1
cells were infected with either H37Rv or FID19. As previously
reported [22], pyroptosis is observed during H37Rv infection,
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fails to inhibit cell death mutant 19 (FID19) transposon mutant revealed that the insertion occurred between nucleotides 305
and 306 of Rv2456c; (B) THP-1 cells were infected with H37Rv, FID19, or a complementation plasmid (FID19: pSL901)
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these proteins were absent. However, during FID19 infection
the loss of PYCARD had no effect on cell death and the loss
of NLRP3 only slightly minimized cell death. These data indi-
cated that pyroptosis mediated by these proteins does not
play a role in cell death during FID19 infection (Fig. 3C). Addi-
tionally, since the knockdown cell lines are unable to secrete
IL-1b [22], it is likely that the cytokine is not responsible for
the death of the host cells.Chemical inhibitors of caspases were used to examine the
role of apoptosis in cell death (Fig. 3D). Since caspase 3 is the
main executioner caspase, an inhibitor was used to prevent
its activation in THP-1 cells. A pan-caspase inhibitor was also
employed to further measure the role of other caspases dur-
ing infection. At 3 days postinfection, H37Rv infection in the
DMSO-treated cells resulted in 12.5 ± 2.0% TUNEL positivity
(Fig. 3D). Addition of the caspase-3 inhibitor or the pan-
caspase inhibitor only slightly reduced cell death, measuring
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Fig. 3 – Fails to inhibit cell death mutant 19-induced cell
death through apoptosis. (A, B) THP-1 cellswere infected at a
multiplicity of infection of 10 and supernatants were
collected at indicated time points; (A) tumor necrosis factor-a
(TNFa); and (B) interleukin-1b (IL-1b) concentrations were
assessedvia enzyme-linked immunosorbent assay; (C)wild-
type or short hairpin RNA knockdown THP-1 cells were
infected at a multiplicity of infection of 10 for 3 days with
indicated strains, fixed, and terminal deoxynucleotidyl
transferase dUTP nick end labeling stained (TUNEL). Data are
a compilation of nine experiments; (D) THP-1 cells were
infected with indicated strains, treated with dimethyl
sulfoxide, 50 lM caspase 3 inhibitor, or 50 lM pan-caspase
inhibitor. Cells were fixed 3-days postinfection and TUNEL
stained. Data are representative of four experiments. *p < .05.
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centage of cell death after FID19 infection in DMSO-treated
cells was 51.6 ± 2.2% and the addition of the inhibitors signif-
icantly reduced cell death (caspase-3 inhibitor: 37.9 ± 2.4, pan-
caspase inhibitor: 25.3 ± 0.1%, p < .05). These data show that
cell death after FID19 infection is mediated by apoptosis
and not pyroptosis.
Enhanced cell death after FID19 infection is a result of reduced
NF-jB activation
NF-jB is a cellular survival pathway that can interact with the
apoptotic pathway, and it has also been shown thatM. tubercu-
losis can interferewith its regulation [32]. To determine if there
were differences in NF-jB activation after H37Rv and FID19
infection, expression of p50 and p65, two subunits of NF-jB,
was measured in nuclear extracts from infected THP-1 cells.There was a reduction in expression of both subunits 2-days
postinfection in FID19-infected cells when compared with
H37Rv or the complemented strain (Fig. 4A). When BAY11-
7082, an inhibitor of inhibitory kappa B-a, was added to THP-
1 cells infected with H37Rv or complemented FID19 there
was an increase in cell death. However, there was no change
when the inhibitor was added to cells infected with FID19
(Fig. 4B). To further confirm differences in NF-jB activation,
protein levels were assayed via western blot (Fig. 4C and D).
FID19-infected cells had reduced protein expression of NF-jB
compared with H37Rv infected cells as early as 2-days postin-
fection. Additionally, FID19 infection also resulted in reduced
levels of Mcl-1, an antiapoptotic protein of the Bcl-2 family
(Fig. 4C and E). NF-jB has been shown to regulate Mcl-1
[33,34]. Taken together, these results indicated that FID19 is
unable to prevent apoptosis through activation of NF-jB.FID19 has enhanced in vivo immunogenicity in mouse studies
Proapoptotic mycobacterial mutants have been shown to
induce enhanced immunity and are thus potential vaccine
candidates [11,35]. In order to quantify the number of func-
tional splenocytes capable of releasing IFNc, we utilized ELI-
SPOT analysis [36,37]. In the CD8+ T cell subset, FID19
infected mice had a mean of 303.6 ± 44.2 SFU/1  106 cells
while H37Rv mice had a statistically lower mean of 139.8 ±
15.7 SFU/1  106 cells (Fig. 5A). There was also a statistical
difference observed in the CD4+ T cell population when
FID19 (360.5 ± 18.6 SFU) was compared to H37Rv (210.3 ± 25.0
SFU) infected mice. We determined the number of bacteria
in the same harvested spleens that were utilized for ELISPOT
analysis. FID19-infected spleens had a significantly reduced
bacterial burden compared to H37Rv infected spleens, even
though the initial bacterial burden was comparable (Fig. 5B).
To further examine the ability of FID19 to induce an
immunological response, mice were infected with FID19 or
H37Rv. Polyfunctionality of T cells can be used as a measure
of vaccine efficacy, as it has been shown to correlate with pro-
tection [38,39]. In our studies, FID19 infection increased both
CD8+ and CD4+ polyfunctional T cell subsets when compared
to H37Rv (Fig. 5C). Intracellular cytokine staining assays for
IL-2, TNFa, and IFNc production revealed that FID19 infection
induced CD8+ T cells that secreted two cytokines at a higher
percentage than H37Rv, 26% versus 20%, respectively. FID19
infection also induced 21% polyfunctional T cells, where
H37Rv only induced 7%. In the CD4+ T cell subset, dual
expression of cytokines was also increased after FID19 infec-
tion (30%) compared with H37Rv (26%). The same was also
true when cells were secreting all three cytokines (FID19:
37%, H37Rv: 30%). These data suggest that FID19 induces a
greater immune response during infection, which is likely
due to enhanced antigen presentation through apoptosis
induction. It also suggests that Rv2456c is important for the
survival of M. tuberculosis within spleens.Discussion
Our work has uncovered many genes that have not yet been
associated with the inhibition of cell death by M. tuberculosis
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identified are diverse in function, suggesting that this patho-
gen has a multitude of mechanisms to ensure its survival by
preventing the death of its host cell. It is interesting to note
that many of the proteins identified in this screen have
unknown functions, and thus present an opportunity to learn
more about the pathogenicity of M. tuberculosis (Table 1). It is
unsurprising that the cell wall processes and metabolism
and respiration functional groups were well represented, as
these are important ways in which mycobacterium interact
with their surroundings and modulate their growth to survive
in host cells. Future studies of these genes will likely elucidate
in vivo survival mechanisms of M. tuberculosis.
Our study did not identify genes previously found to have
a role in cell death [6,7,9,11,15,40] caused by M. tuberculosis.There was overlap of a single gene, Rv1436, between the
screen in this work and a screen performed by Danelishvili
et al. [9]. The screens differed in both the cell types used as
well as in themechanism of detection. In our study, A549 cells
were initially screened for membrane damage induced by
9400 transposon mutants and further confirmed through
THP-1 cell infection followed by TUNEL staining (Fig. 1),
whereas Danelishvili et al. [9] screened 5000 mutants in
U937 andmonitored for cellular detachment and ELISA confir-
mation. Additional genes that may interact or have homology
with other genes identified in the literature. For example,
Rv1624c (FID12) is a conserved hypothetical protein with some
similarity to M. tuberculosis NuoK. This gene lies in an operon
with NuoG, part of a nicotinamide adenine dinucleotide +
hydrogen dehydrogenase found to aid in the inhibition of
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Fig. 5 – Fails to inhibit cell death mutant 19 has enhanced
immunogenicity when compared with parental strain
H37Rv. (A) C57BL/6 J mice were infected with indicated
strain for 3 weeks. Splenocytes were then isolated,
stimulated for 24 h with either a CD8+-specific antigen
(Tb10.4) or a CD4+-specific antigen (Ag85) for enzyme-linked
immunoSpot analysis. Data are representative of three
experiments (2 experiments contained 4 mice/group and
the third experiment contained 8 mice/group); (B)
splenocytes were isolated, stimulated for 24 h with either a
CD8+-specific antigen (Tb10.4) or a CD4+-specific antigen
(Ag85). After the incubation, the cells were stained for CD4+
and CD8+ surface markers and interleukin-2, interferon-c
(IFNc), and tumor necrosis factor-a for intracellular cytokine
staining analysis. The data show a representative figure of a
standard experiment with four mice/group. Note:
CFU = colony forming units; SFU = spot forming units.
*p < .05.
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was identified in our screen, which is immediately upstream
of Rv1980c (MPT64), and Wang et al. [32] recently established
that MPT64 is able to inhibit apoptosis through NF-jB. Based
on the discovery of the different functional groups ofM. tuber-
culosis FID proteins, it seems evident that M. tuberculosisutilizes many mechanisms to inhibit death of host cells and
our screen has uncovered novel genes important in that goal.
These results also suggest that our screen was not compre-
hensive and that there are likely many more genes that play
a role in cell death inhibition. Many factors could have pre-
vented our identification of known genes, such as the time
points utilized, the host cell type infected, or the lack of a
transposon insertion in the gene. There also may be some
genes that are essential for the growth of M. tuberculosis and
thus will never be identified in a screen such as this.
FID19 was identified as a priority mutant because of its
strong induction of cell death (Figs. 1 and 2B) and the
enhanced in vitro immunogenicity data (Fig. 2D). Sequencing
revealed that FID19 has a transposon insertion in Rv2456c
(Fig. 2A), an integral membrane transport protein. Orthologs
can be found in other pathogenic mycobacteria, including
Mycobacterium bovis,Mycobacterium avium,Mycobacterium ulcer-
ans, and Mycobacterium marinum, suggesting that it has a role
in virulence. Complementation via a replicating plasmid
(Fig. 2B) further confirmed the finding that the loss of
Rv2456c was responsible for the enhanced cell death pheno-
type observed. The directionality of the transport and the
identity of the substrate of the protein are not currently
known. The molecule may play a direct or indirect role in
the inhibition of apoptosis in wild-typeM. tuberculosis through
activation of NF-jB (Fig. 4).
Rv2456c is the second gene in a predicted two-gene
operon, with Rv2457c (ClpX) being the first gene (Fig. 2A). In
M. tuberculosis, ClpXwas found to be upregulated during infec-
tions in THP-1 cells [41]. ClpX is an essential gene [42] and can
act as a chaperone molecule when alone or as a protease
when associated with ClpP [43]. Without the presence of this
protease, both Listeria monocytogenes and Streptococcus pneumo-
niae lose the ability to survive in macrophages and in mice,
indicating a role in virulence [44–46]. The ClpXP protease
was also found to regulate RecA in bacterial cell death by
Escherichia coli [47]. Considering that this protein has been
established in other systems as playing a role in virulence,
future studies will determine the interaction between ClpX
and Rv2456c and its effect on the survival of M. tuberculosis.
FID19 induces cell death through caspase-3 mediated
apoptosis. This is supported by the fact that chemical inhibi-
tion of caspase 3 is able to reduce cell death (Fig. 3D), as well
as the finding that FID19 induces greater levels of TNFa secre-
tion in comparison to H37Rv (Fig. 3A). The cells infected with
H37Rv were not impacted by the presence of the inhibitor
(Fig. 3D), likely because the bacterium is already inhibiting
the pathway [7,8]. Cytokine secretions are vital for cell signal-
ing and are commonly assayed during cell death experimen-
tation. The presence of the inflammatory cytokine IL-1b could
indicate the activation of pyroptosis (Fig. 3B), but others have
shown that IL-1b can be cleaved independently of caspase-1
activation during mycobacterial infection [22]. In shRNA
knockdown cell lines, cell death induced by FID19 (Fig. 3C)
was not impacted by the loss of PYCARD, an adaptor molecule
important for the cleavage of IL-1b. The loss of NLRP3 does
reduce TUNEL positivity, but this decrease is also observed
in H37Rv infection. It is unclear if NLRP3 plays a PYCARD-
independent role in pyroptosis. IL-1b is not important in the
induction of cell death by FID19, as the shRNA knockdown
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impaired in their ability to undergo cell death (Fig. 3B).
Recently, Bai et al. [48] showed that there is reduced sur-
vival ofM. tuberculosiswhen NF-jB is inhibited. Another group
showed that Rv3402c is important for the activation of NF-jB
[49]. Further, they showed that TNFa and IL-1b were also
increased, similar to what was observed after FID19 infection.
Our studies have also shown that the expression of Rv2456c
resulted in increased NF-jB activation and a loss of Mcl-1
expression (Fig. 4C), which reduced host cell apoptosis.
Since increased apoptosis induced by M. tuberculosis is
important to immunogenicity [11], this work sought to deter-
mine if any of the mutants were able to modulate the
immune response differently than the parental strain
H37Rv. Mouse models currently serve as the most common
method of studying tuberculosis immunology [50–52]. FID19
consistently showed enhanced immunogenicity in both the
CD8+ and CD4+ T cell subsets (Fig. 5). This is a promising
result, as the lack of a CD8+ cell response is hypothesized to
be a reason why the Bacillus Calmette–Gue´rin vaccine is inef-
ficient at protecting against pulmonary tuberculosis. Unlike
FID19, another proapoptotic mutant, DsecA2, showed
enhanced priming of the adaptive immunity only in the
CD8+ cell subset [11].Conclusion
We have identified several genes important in the inhibition
of cell death by M. tuberculosis have been identified by our
study. A transposon mutant with a disruption in Rv2456c,
known in this work as FID19, was found to cause infected cells
to undergo enhanced cell death, whichmay be due to a failure
to induce NF-jB activation and a subsequent result of
caspase-3 mediated apoptosis. Future studies will look at
longer time points in mice to determine how long FID19 is
able to survive within mice. Additionally, since this mutant
had enhanced CD4+ and CD8+ T cell responses when com-
pared with H37Rv, we will further examine its efficacy as a
potential vaccine candidate.Conflicts of interest
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